Herbalife - HLF STOCK NEWS

Herbalife Nutrition (NYSE: HLF) announced that its executives will present at three financial conferences in June 2022. Key speakers include John Agwunobi, Alex Amezquita, and Eric Monroe. They will engage in discussions on opportunities in weight management, sports nutrition, and growth strategies. The events are: the Bernstein’s 38th Annual Strategic Decisions Conference on June 2 in New York, dbAccess Global Consumer Conference on June 16 in Paris, and the Jefferies Consumer Conference on June 22 in Nantucket. Investors can access presentation materials online.

Herbalife Nutrition Ltd. (NYSE: HLF) reported Q1 2022 financial results, showing net sales of $1.3 billion, an 11% decline from Q1 2021. Reported diluted EPS was $0.96, down from $1.33 a year earlier. Despite a 7% drop in volume points, the company expects a turnaround in net sales by Q4 2022, aided by in-person sales events and new initiatives. Adjusted EBITDA reached $185.6 million, just above guidance. Full-year sales guidance has been lowered to a range of down 10% to down 4%. The company is implementing pricing and cost measures in response to inflationary pressures.

Herbalife Nutrition has achieved the North Carolina Department of Labor Silver Award for the 6th year and its first Gold Award, recognizing its commitment to safety at its Winston-Salem facility. This facility, which opened in 2014, spans 800,000 square feet and produces around 400,000 units daily. Additionally, Herbalife holds ISO certifications for health and safety standards, further demonstrating its dedication to employee welfare. The company operates five manufacturing facilities globally and emphasizes quality control through its accredited laboratories.

Herbalife Nutrition (NYSE: HLF) has nominated Celine Del Genes to its Board of Directors ahead of the Annual General Meeting. Del Genes, currently the Global General Manager at adidas AG, brings over 20 years of marketing and business leadership experience. CEO John Agwunobi believes her expertise will significantly enhance the Board's capabilities and drive future growth for the company. With this nomination, Herbalife's Board will consist of 11 directors, emphasizing diversity. Del Genes is expected to leverage her experience to create greater shareholder value.

Herbalife Nutrition Ltd. (NYSE: HLF) will announce its first quarter 2022 financial results on May 3, 2022, after market close. A conference call with senior management will take place at 5:30 p.m. ET to discuss the results and current business trends. The call can be accessed via phone or through a live webcast on the company's investor relations website. An audio replay will be available post-call. Herbalife Nutrition offers nutrition products and opportunities through independent distributors in 95 markets, aiming for 50 million positive impacts by 2030.

Herbalife Nutrition (NYSE: HLF) announces its participation in several global science and industry conferences in Q2 2022. The events aim to address sustainable agriculture, nutrition's role in health, and supply chain resilience. Notable presentations include discussions on nutrition strategies for athletes and the impact of nutrition on non-communicable diseases. Executives from Herbalife will engage with various professionals to share advancements in nutrition science. The company’s ongoing commitment aims for 50 million positive impacts by 2030.

Herbalife Nutrition (NYSE: HLF) announced that Gary Swanson, Senior VP of Global Quality, will present at the 2022 AOAC INTERNATIONAL Midyear Meeting on March 17, 2022, in Gaithersburg, MD. His presentation, titled “Quality Management System Framework for Dietary Supplements Containing Botanicals,” will discuss strategies for bringing dietary supplements to market.

Swanson emphasized that Herbalife implements strict quality control from product conception through to consumer delivery. This meeting also highlights advancements in food safety and integrity.

Herbalife Nutrition Ltd. announced that Michael O. Johnson, former Chairman and CEO, will be a nominee for its Board of Directors at the upcoming Annual General Meeting. Johnson, a significant investor with decades of experience, aims to enhance the Board's expertise to support the Company's growth. This nomination follows the addition of three new board members in March 2021, bringing the total to ten directors. Johnson previously led the Company from 2003 to 2017, significantly boosting sales and expanding global operations. His return is seen as vital for driving future growth and governance.